Increased operational expenses and reduced cash reserves were cited. Roivant Sciences reports improved EPS for the second ...

Roivant Sciences Ltd (ROIV) showcases robust financial health with $5.4 billion in cash and no debt, while navigating competitive pressures and strategic opportunities.

Good day and thank you for standing by. Welcome to the Roivant second-quarter 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I ...

Indian-American entrepreneur and author Vivek Ramaswamy, known for founding Roivant Sciences, has become a prominent figure ...

Vivek Ramaswamy, 39, is a multimillionaire former biotech executive, who will lead the newly-established Department of ...

At the young age of 39, Trump's newly created Department of Government Efficiency (DOGE) co-director and a billionaire, Vivek ...

President-elect Trump announced that billionaire Elon Musk and former GOP presidential candidate Vivek Ramaswamy will lead ...

Together, these two wonderful Americans will pave the way for my Administration to dismantle Government Bureaucracy, slash ...

TD Cowen analyst Yaron Werber maintained a Buy rating on Roivant Sciences (ROIV – Research Report) yesterday. The company’s shares closed yesterday at $11.64. According to TipRanks, Werber is a 5-star ...

Vivek Ramaswamy will lead, together with Elon Musk, the Department of Government Efficiency (D.O.G.E) in the Donald Trump ...

Trump made the announcement on social media, fulfilling a promise during the campaign to give Musk sweeping oversight of ...